CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- 4 Option exercise Chief Legal Officer acquired 62,500 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,772,781 shares at $3.30 ($15,750,177)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise Chief Financial Officer acquired 40,293 shares (option exercise)
- 4 Option exercise Chief Commercial Officer acquired 42,110 shares (option exercise)
- 4 Option exercise President and CEO acquired 321,100 shares (option exercise)
Page 3 of 67 · 1,325 filings